Medicare Enrolled
Dr. James Mobley, M.D.
Internal Medicine · Plano, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mobley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mobley?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mobley
Dr. James Mobley is an internal medicine specialist in Plano, TX, with 11 years of NPI registration. Based on federal Medicare data, Dr. Mobley performed 93,106 Medicare services across 2,761 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mobley received a total of $2,008 from 35 pharmaceutical and/or device companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mobley is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 0% volume in TX
$2,008 industry payments
Medicare Practice Summary
Medicare Utilization ↗93,106
Medicare services
Top 0% in TX for internal medicine
2,761
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,464 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 30,600 | $0 | $5 |
| Oxaliplatin chemotherapy injection | 14,360 | $0 | $33 |
| Pembrolizumab injection (Keytruda) | 10,000 | $43 | $137 |
| Iron sucrose injection (Venofer) | 7,200 | $0 | $2 |
| Paclitaxel chemotherapy injection | 5,336 | $0 | $8 |
| Contrast dye for imaging (iodine-based) | 4,695 | $0 | $3 |
| Darbepoetin injection (Aranesp) for anemia | 3,720 | $2 | $20 |
| Injection, bortezomib, 0.1 mg | 3,570 | $4 | $116 |
| Dexamethasone injection (steroid) | 2,673 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 1,040 | $0 | $24 |
| Injection, leucovorin calcium, per 50 mg | 808 | $3 | $25 |
| Anti-nausea injection (Aloxi/palonosetron) | 640 | $1 | $114 |
| Injection, fluorouracil, 500 mg | 587 | $2 | $13 |
| Comprehensive metabolic blood panel | 546 | $10 | $64 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 540 | $22 | $157 |
| Blood draw (venipuncture) | 518 | $8 | $20 |
| Complete blood count (CBC) with differential | 514 | $8 | $36 |
| Administration of chemotherapy into vein, 1 hour or less | 352 | $97 | $707 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 348 | $83 | $1,348 |
| Injection of additional new drug or substance into vein | 268 | $12 | $108 |
| Magnesium level test | 234 | $7 | $29 |
| Injection, potassium chloride, per 2 meq | 215 | $0 | $1 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 202 | $54 | $211 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 195 | $46 | $313 |
| Office visit, established patient (30-39 min) | 195 | $95 | $368 |
| Injection, magnesium sulfate, per 500 mg | 194 | $1 | $6 |
| Phosphate level test | 188 | $5 | $24 |
| Office visit, established patient, complex (40-54 min) | 182 | $134 | $496 |
| Cyclophosphamide, 100 mg | 181 | $16 | $203 |
| Injection, carboplatin, 50 mg | 169 | $2 | $300 |
| Hospital follow-up visit, moderate complexity | 160 | $61 | $247 |
| Injection, zoledronic acid, 1 mg | 160 | $6 | $431 |
| Infusion, normal saline solution , 1000 cc | 143 | $2 | $19 |
| Injection, diphenhydramine hcl, up to 50 mg | 131 | $1 | $7 |
| Administration of chemotherapy into vein, each additional hour | 127 | $21 | $161 |
| Lactate dehydrogenase (enzyme) level | 126 | $6 | $31 |
| Hospital follow-up visit, high complexity | 123 | $90 | $357 |
| Administration of additional new drug or substance into vein, 1 hour or less | 118 | $49 | $344 |
| Unclassified drugs | 108 | $1 | $8 |
| Drug injection, under skin or into muscle | 99 | $10 | $96 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 97 | $342 | $1,722 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 84 | $124 | $500 |
| Infusion into a vein for hydration, 31-60 minutes | 82 | $24 | $256 |
| Reticulated (young) platelet measurement | 68 | $35 | $143 |
| Ferritin level test (iron stores) | 63 | $13 | $60 |
| Iron level test | 63 | $6 | $27 |
| Iron binding capacity test | 63 | $9 | $35 |
| Administration of additional new drug or substance into vein using push technique | 63 | $42 | $289 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 62 | $15 | $94 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 56 | $24 | $145 |
| Irrigation of implanted venous access drug delivery device | 53 | $17 | $114 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 51 | $131 | $3,675 |
| Microscopic examination for white blood cells with manual cell count | 50 | $4 | $22 |
| Complete blood count (CBC), automated | 50 | $6 | $34 |
| Ct scan of chest with contrast | 48 | $38 | $821 |
| Uric acid level test | 48 | $4 | $25 |
| New patient office visit (45-59 min) | 47 | $125 | $565 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 47 | $1 | $19 |
| Infusion into a vein for hydration, each additional hour | 46 | $10 | $75 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 46 | $16 | $100 |
| Office visit, established patient (20-29 min) | 45 | $63 | $250 |
| Administration of chemotherapy into vein using push technique | 42 | $73 | $500 |
| CT scan of abdomen and pelvis with contrast | 39 | $140 | $1,067 |
| New patient office visit, complex (60-74 min) | 37 | $165 | $709 |
| Drawing of blood for a medical problem | 30 | $61 | $264 |
| Application of on-body injector for under skin injection | 29 | $14 | $96 |
| Initial hospital admission, moderate complexity | 27 | $100 | $470 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 25 | $90 | $657 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 20 | $1,152 | $4,802 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 19 | $1 | $17 |
| CT scan of chest, without contrast | 15 | $22 | $686 |
| Red blood count automated, with additional calculations | 13 | $5 | $26 |
| Initial hospital admission, high complexity | 13 | $133 | $694 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
34.2% high complexity
61.5% medium
4.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,008
Total received (2022-2024)
Avg $669/year across 3 years
Top 30% in TX for internal medicine
35
Companies
98
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,008 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,399
2023
$369
2022
$240
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$309
Novartis Pharmaceuticals Corporation
$217
E.R. Squibb & Sons, L.L.C.
$197
AstraZeneca Pharmaceuticals LP
$111
Pharmacyclics LLC, an AbbVie Company
$100
EMD Serono, Inc.
$82
Astellas Pharma US Inc
$71
Incyte Corporation
$66
PFIZER INC.
$65
Mirati Therapeutics, Inc.
$56
JAZZ PHARMACEUTICALS INC.
$54
Adaptive Biotechnologies Corporation
$47
Exelixis Inc.
$41
Kite Pharma, Inc.
$40
Takeda Pharmaceuticals U.S.A., Inc.
$40
Regeneron Healthcare Solutions, Inc.
$39
Celgene Corporation
$39
Karyopharm Therapeutics Inc.
$39
Bayer Healthcare Pharmaceuticals Inc.
$39
PharmaEssentia USA Corporation
$34
BeiGene USA, Inc.
$32
Daiichi Sankyo Inc.
$27
Janssen Biotech, Inc.
$26
Stemline Therapeutics Inc.
$25
GENZYME CORPORATION
$24
CTI BioPharma Corp.
$24
Eisai Inc.
$22
Genentech USA, Inc.
$22
Genmab U.S., Inc.
$22
MorphoSys, US Inc.
$22
Blueprint Medicines Corporation
$19
Legend Biotech USA Inc.
$16
GlaxoSmithKline, LLC.
$16
SOBI, INC
$16
ABBVIE INC.
$14
Top 3 companies account for 36.0% of total payments
Associated products mentioned in payments ›
ALUNBRIG · AYVAKIT · BAVENCIO · BESREMI · BRUKINSA · CABOMETYX · CALQUENCE · Cabometyx · DARZALEX · DOPTELET · ENHERTU · Enhertu · Epkinly · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · OJJAARA · OPDIVO · OPDUALAG · Orserdu · PADCEV · PLUVICTO · Phesgo · Pomalyst · SARCLISA · SCEMBLIX · Stivarga · VENCLEXTA · Vonjo · XPOVIO · Xospata · Yescarta · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $2 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
2,127
Per 100K population
190.5
County median income
$117,588
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mobley is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mobley experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Mobley performed 30,600 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mobley receive payments from pharmaceutical companies?
Yes. Dr. Mobley received a total of $2,008 from 35 companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mobley's costs compare to other internal medicine physicians in Plano?
Dr. Mobley's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mobley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Plano
Browse internal medicine physicians in Plano ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology